Entyvio (vedolizumab) 300 mg, 1 vial, Takeda Entyvio (vedolizumab) is used for approved inflammatory bowel disease indications including ulcerative colitis. Medicine delivery from Europe within 4-5 days with storage conditions maintained. Payment on delivery. Order at +380996042415 via Viber or WhatsApp.
Delivery methods
- Delivery of non-temperature-controlled medicines to Chisinau - $25.
Delivery of temperature-controlled medicines to Chisinau - $50.
Up to 5 packages can be sent per shipment. The price applies to one shipment. - Pickup from Odesafree
- Shipping within Ukraine by Nova Poshta at the carrier's rates.
Payment in UAH upon receipt of the order.
Delivery time
- Originator medicines: 5-7 days
- Generic medicines: 3-4 days
Payment methods
- Bank transfer to the settlement account after receiving the order
- Payment upon pickup in Odesa
Indications
- Treatment of the active course of moderate to severe non-specific ulcerative colitis in adult patients in the absence of an adequate response, loss of response or intolerance to standard therapy or tumor necrosis factor alpha (TNF-α) antagonists.
- Treatment of active moderate to severe Crohn's disease in adult patients with inadequate response, loss of response or intolerance to standard therapy or tumor necrosis factor alpha (TNF-α) antagonists.
- Trade name:Entyvio
- Chemical name:Vedolizumab
- Dosage:300 mg
- Quantity:1
- Dosage form:Vial
No reviews yet
